Global Direct-acting Antiviral Drug Market Report 2022-2027: Availability of Directly-Acting Antiviral Medicines Presents Opportunities – ResearchAndMarkets.com

Global Direct-acting Antiviral Drug Market Report 2022-2027: Availability of Directly-Acting Antiviral Medicines Presents Opportunities – ResearchAndMarkets.com




Global Direct-acting Antiviral Drug Market Report 2022-2027: Availability of Directly-Acting Antiviral Medicines Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Direct-acting Antiviral Drug Market (2022-2027) by Type, Indication, Route, Distribution Channel, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Direct-acting Antiviral Drug Market is estimated to be USD 9.41 Bn in 2022 and expected to reach USD 17.8 Bn by 2027, growing at a CAGR of 13.6%.

Market Dynamics

Drivers

  • Increasing Prevalence and Incidence of Hepatocellular Carcinoma and Liver Cirrhosis
  • Increasing Product Development and Launch of New Direct-Acting Antiviral Medicines
  • Growing Awareness and Improving Healthcare in Emerging Countries

Restraints

  • Difficulties in Obtaining Insurance Approval for New HCV Treatment Regimens
  • High Cost of Drugs

Opportunities

  • Increasing Support from Government Authorities & Social Healthcare Associations
  • Availability of Directly-Acting Antiviral Medicines

Challenges

  • Patent Expiration of Branded Direct-Acting Antiviral
  • Unmeasured Side Effects Associated with the Direct-Acting Antiviral Drugs

Market Segmentations

The Global Direct-acting Antiviral Drug Market is segmented based on Type, Indication, Route, Distribution Channel, and Geography.

  • By Type, the market is classified into NS3/4A Protease, NS5A Protein, and NS5B RNA-Dependent RNA polymerase.
  • By Indication, the market is classified into HIV Infection/ AIDS, Hepatitis C Virus, Influenza and Prophylaxis.
  • By Route, the market is classified into Intravenous, Oral, Subcutaneous, and Topical.
  • By Distribution Channel, the market is classified into Hospital Pharmacy, Online Drug Store, and Retail Pharmacy.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Direct-acting Antiviral Drug Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Direct-acting Antiviral Drug Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Direct-acting Antiviral Drug Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s competitive positioning tool.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Direct-acting Antiviral Drug Market, By Type

7 Global Direct-acting Antiviral Drug Market, By Indication

8 Global Direct-acting Antiviral Drug Market, By Route

9 Global Direct-acting Antiviral Drug Market, By Distribution Channel

10 Americas’ Direct-acting Antiviral Drug Market

11 Europe’s Direct-acting Antiviral Drug Market

12 Middle East and Africa’s Direct-acting Antiviral Drug Market

13 APAC’s Direct-acting Antiviral Drug Market

14 Competitive Landscape

15 Company Profiles

16 Appendix

Companies Mentioned

  • Amneal Pharmaceuticals, LLC
  • Atea Pharmaceuticals, Inc.
  • Auro Pharma Inc.
  • Bristol-Myers Squibb Company
  • Camber Pharmaceuticals, Inc.
  • Cipla USA Inc.
  • F. Hoffmann-La Roche Ag
  • Genentech, Inc.
  • Marcan Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Natco Pharma
  • Novartis Ag

For more information about this report visit https://www.researchandmarkets.com/r/1d3hc0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900